COMMUNIQUÉS West-GlobeNewswire

Correction: Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
23/07/2026
PROMIXX set out to fix what defined the manual shaker category, replacing the wire mixing ball with the Snap-Fit Agitator: a lid-locked mixing grid Cardiff, July 23, 2026 (GLOBE NEWSWIRE) -- The Snap-Fit Agitator is an [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
23/07/2026
ATLANTA, July 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its second quarter results before the market open on Thursday, August [...]
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
23/07/2026
- All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - - Independent Safety Monitoring Committee to review Cohort 1 safety and tolerability [...]
Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology
23/07/2026
CEO Tanay Tandon honored as Executive of the Year MOUNTAIN VIEW, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Commure , the leading AI-native healthcare RCM & Ambient platform, today announced it has been recognized [...]
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
23/07/2026
Sòphia High Tech designs and manufactures ROMAN units for the remote inspection and maintenance of the RFX-mod2 fusion experiment, combining its precision manufacturing capabilities with the robotics expertise of [...]
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
23/07/2026
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
23/07/2026
Group sales were +6% at constant exchange rates (CER) 1 , -2% when reported in CHF and +8% in USD 2 , in the first six months, driven by high demand for innovative medicines and diagnostics. Pharmaceuticals Division [...]
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
23/07/2026
Strong second quarter performance with $1.5 billion in global product net sales, representing 60% year-over-year growth and 17% quarter-over-quarter growth Successfully launched VYVGART and VYVGART Hytrulo in anti-AChR [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
22/07/2026
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, [...]
The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship
22/07/2026
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine. Los Angeles [...]
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
FREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the second quarter of 2026 after [...]
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the [...]
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
22/07/2026
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market [...]
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
22/07/2026
HUNTSVILLE, Ala., July 22, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its proprietary POZ Platform ™ drug [...]
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/07/2026
FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective July 17, 2026, it granted stock options to purchase [...]
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]

Pages